Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2010

01-03-2010 | Brief Report

Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting

Authors: P. J. Lillie, D. Andrews, K. Eaves, T. C. Darton, A. L. N. Chapman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2010

Login to get access

Excerpt

Skin and soft tissue infections are amongst the most common infections presenting to secondary care, and have been reported to be increasing in frequency [1, 2]. While many cases can be treated with oral antibiotics alone, some do require intravenous (IV) therapy; since cellulitis is rarely life- or limb-threatening, a high proportion of these cases may be suitable for outpatient parenteral therapy. However, this may mean that patients are reviewed by a physician less frequently than as an inpatient, and it would, therefore, be useful to have some means of predicting the likely duration of IV therapy to aid decisions such as the frequency of medical reviews or the most appropriate type of IV access. While previous studies have looked at factors affecting the duration of hospitalisation for cellulitis [37], none, to our knowledge, have investigated factors associated with the duration of IV therapy as an outpatient. We, therefore, retrospectively analysed data from the Outpatient and Home Parenteral Antibiotic Therapy (OHPAT) service at our institution to ascertain factors predictive of the duration of IV therapy for cellulitis. …
Literature
1.
go back to reference Hersh AL, Chambers HF, Maselli JH, Gonzales R (2008) National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 168:1585–1591CrossRefPubMed Hersh AL, Chambers HF, Maselli JH, Gonzales R (2008) National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 168:1585–1591CrossRefPubMed
2.
go back to reference Hayward A, Knott F, Petersen I, Livermore DM, Duckworth G, Islam A, Johnson AM (2008) Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. Emerg Infect Dis 14:720–726CrossRefPubMed Hayward A, Knott F, Petersen I, Livermore DM, Duckworth G, Islam A, Johnson AM (2008) Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. Emerg Infect Dis 14:720–726CrossRefPubMed
3.
go back to reference Lazzarini L, Conti E, Tositti G, de Lalla F (2005) Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 51:383–389CrossRefPubMed Lazzarini L, Conti E, Tositti G, de Lalla F (2005) Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 51:383–389CrossRefPubMed
4.
go back to reference Cox NH, Colver GB, Paterson WD (1998) Management and morbidity of cellulitis of the leg. J R Soc Med 91:634–637PubMed Cox NH, Colver GB, Paterson WD (1998) Management and morbidity of cellulitis of the leg. J R Soc Med 91:634–637PubMed
5.
go back to reference Carratalà J, Rosón B, Fernández-Sabé N, Shaw E, del Rio O, Rivera A, Gudiol F (2003) Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 22:151–157PubMed Carratalà J, Rosón B, Fernández-Sabé N, Shaw E, del Rio O, Rivera A, Gudiol F (2003) Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 22:151–157PubMed
6.
go back to reference Peralta G, Padrón E, Roiz MP, De Benito I, Garrido JC, Talledo F, Rodríguez-Lera MJ, Ansorena L, Sánchez MB (2006) Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis 25:619–626CrossRefPubMed Peralta G, Padrón E, Roiz MP, De Benito I, Garrido JC, Talledo F, Rodríguez-Lera MJ, Ansorena L, Sánchez MB (2006) Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis 25:619–626CrossRefPubMed
7.
go back to reference Morpeth SC, Chambers ST, Gallagher K, Frampton C, Pithie AD (2006) Lower limb cellulitis: features associated with length of hospital stay. J Infect 52:23–29CrossRefPubMed Morpeth SC, Chambers ST, Gallagher K, Frampton C, Pithie AD (2006) Lower limb cellulitis: features associated with length of hospital stay. J Infect 52:23–29CrossRefPubMed
8.
go back to reference Carter K, Kilburn S, Featherstone P (2007) Cellulitis and treatment: a qualitative study of experiences. Br J Nurs 16:S22–S24, S26–S28PubMed Carter K, Kilburn S, Featherstone P (2007) Cellulitis and treatment: a qualitative study of experiences. Br J Nurs 16:S22–S24, S26–S28PubMed
9.
go back to reference Seaton RA, Bell E, Gourlay Y, Semple L (2005) Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone. J Antimicrob Chemother 55:764–767CrossRefPubMed Seaton RA, Bell E, Gourlay Y, Semple L (2005) Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone. J Antimicrob Chemother 55:764–767CrossRefPubMed
Metadata
Title
Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting
Authors
P. J. Lillie
D. Andrews
K. Eaves
T. C. Darton
A. L. N. Chapman
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0855-9

Other articles of this Issue 3/2010

European Journal of Clinical Microbiology & Infectious Diseases 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.